{"organizations": [], "uuid": "38a2e1926dca1317a42675a009aa1834c7baaab5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180306.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-marinus-pharmaceuticals-provides-b/brief-marinus-pharmaceuticals-provides-business-update-and-2017-financial-results-idUSASB0C8XZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Marinus Pharmaceuticals Provides Business Update And 2017 Financial Results", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.015, "site_type": "news", "published": "2018-03-06T20:43:00.000+02:00", "replies_count": 0, "uuid": "38a2e1926dca1317a42675a009aa1834c7baaab5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-marinus-pharmaceuticals-provides-b/brief-marinus-pharmaceuticals-provides-business-update-and-2017-financial-results-idUSASB0C8XZ", "ord_in_thread": 0, "title": "BRIEF-Marinus Pharmaceuticals Provides Business Update And 2017 Financial Results", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "marinus pharmaceuticals inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 6 (Reuters) - Marinus Pharmaceuticals Inc:\n* MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND 2017 FINANCIAL RESULTS\n* MARINUS - ‍EXPECTS TO INITIATE A GLOBAL, PIVOTAL STUDY IN CDKL5 DEFICIENCY DISORDER IN MID-2018​\n* MARINUS PHARMACEUTICALS - ‍ BELIEVE CASH, CASH EQUIVALENTS AS OF DEC 31, 2017 TO ENABLE FUNDING OPERATING EXPENSES AND CAPEX NEEDS INTO 2020​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-06T20:43:00.000+02:00", "crawled": "2018-03-07T19:20:44.023+02:00", "highlightTitle": ""}